LIANBIO's ticker is and the CUSIP is 53000N108. A total of 38 filers reported holding LIANBIO in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,310,618 | -34.6% | 3,564,173 | 0.0% | 0.02% | -33.3% |
| Q2 2023 | $8,126,314 | +16.9% | 3,564,173 | 0.0% | 0.03% | 0.0% |
| Q1 2023 | $6,950,137 | +18.9% | 3,564,173 | 0.0% | 0.03% | +13.8% |
| Q4 2022 | $5,845,244 | -17.6% | 3,564,173 | 0.0% | 0.03% | -12.1% |
| Q3 2022 | $7,093,000 | -7.9% | 3,564,173 | 0.0% | 0.03% | -5.7% |
| Q2 2022 | $7,699,000 | +38.3% | 3,564,173 | +137.6% | 0.04% | +59.1% |
| Q1 2022 | $5,565,000 | -39.8% | 1,500,000 | 0.0% | 0.02% | -18.5% |
| Q4 2021 | $9,240,000 | – | 1,500,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCHF (GPE), LLC | 937,500 | $1,397 | 25.49% |
| Vida Ventures Advisors, LLC | 2,282,084 | $3,400,305 | 5.26% |
| Perceptive Advisors | 57,558,451 | $85,762,091 | 2.86% |
| 22NW, LP | 2,211,678 | $3,295,400 | 2.35% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,303,573 | $4,922,324 | 0.69% |
| TANG CAPITAL MANAGEMENT LLC | 1,800,000 | $2,682,000 | 0.38% |
| Affinity Asset Advisors, LLC | 672,357 | $1,001,812 | 0.28% |
| MYDA Advisors LLC | 200,000 | $298,000 | 0.10% |
| Logos Global Management LP | 280,000 | $417,200 | 0.06% |
| Old Well Partners, LLC | 32,200 | $47,978 | 0.04% |